Get the Daily Brief
Latest Biotech News
Regencell Stock Surge: 64,000% Rally Then Sharp Fall
Regencell Bioscience Holdings, a Hong Kong biotech focused on Traditional Chinese Medicine for neurocognitive disorders, experienced an extraordinary stock price surge of up to 82,000% YTD in...
Biopharma Layoffs Hold Steady Amid Big Pharma Cuts
The biopharma industry recorded 62 layoff rounds in Q3 2025, consistent with previous quarters and on track to surpass 2024's total by 27%. Notably, Novo Nordisk cut 9,000 jobs, Merck eliminated...
FDA and Industry Leaders Plan PDUFA Reauthorization Talks
CDER and CBER leaders at the FDA are scheduled to meet with industry groups BIO and PhRMA to discuss the Prescription Drug User Fee Act (PDUFA) reauthorization. The talks will focus on leveraging...
AI and Computational Advances Accelerate Biotech Research
Recent innovations in artificial intelligence and computational modeling are reshaping biotech. Notable developments include emergent deep learning frameworks improving protein interaction...
Emerging Molecular Insights in Cancer Biology and Treatment
Recent studies reveal critical molecular mechanisms influencing cancer aggressiveness and therapeutic response. Highlights include identification of metabolic activity of visceral fat driving...
Traditional Chinese Medicine Explored in Neurocognitive and Metabolic Disorders
Studies continue to explore the biomedical potential of Traditional Chinese Medicine (TCM). Regencell’s TCM formulations for neurocognitive disorders attracted speculative finance. Separately,...
Pediatric Care Advances: Diagnostics, Nursing, and Therapeutics
Recent pediatric research highlights improvements in clinical care. Innovations include advances in pediatric flexible bronchoscopy techniques, meta-analytical evidence cautioning against...
Healthcare Workforce Challenges: Nurse Perspectives and Workplace Dynamics
Multiple studies examine nursing workforce issues. Research reveals the impact of abusive supervision on nurses leading to deviant acts, the importance of psychological resilience in nursing...
Drug Pricing Policies and Market Dynamics Evolve in 2025
Pharmaceutical policy and market trends are shifting. The Trump administration finalizes Medicare Part D Most Favored Nation (MFN) rule, setting precedent for presidential drug price negotiations....
Biotech Financing and IPO Landscape Expands in Hong Kong
Investment activity is surging in Asia’s biotech sector. Eight companies have filed on the Hong Kong Stock Exchange with two seeking dual listings. NASDAQ firms Ocular, Ovid, and Palisade have...
Jazz-Roche Lung Cancer Combo Gains Early FDA Nod
The U.S. Food and Drug Administration has approved a first-line maintenance combination therapy for extensive-stage small-cell lung cancer. The combo includes Jazz Pharmaceuticals' Zepzelca...
Biopharma Layoffs Persist As Industry Faces Restructuring
The biopharmaceutical sector continues to experience significant workforce reductions, with 62 layoff rounds reported in Q3 2025, nearly matching the earlier quarters. Notable cuts include Novo...
AI-Driven Advances Accelerate Drug Discovery and Prognosis
Recent breakthroughs harness artificial intelligence to transform drug discovery and cancer prognosis. Nanyang Biologics plans a $1.5 billion Nasdaq SPAC combining machine learning with natural...
FDA Cell and Gene Therapy Listening Session Highlights Development Strategies
The FDA’s Office of Therapeutic Products convened a public listening session focusing on leveraging prior knowledge to streamline cell and gene therapy (CGT) product development and review....
New AI and Computing Models Propel Scientific Research Efficiency
Innovations in AI and computing are revolutionizing scientific productivity and research methodologies. Mercor’s AI Productivity Index benchmarks real-world AI economic value, engaging STEM...
Groundbreaking Molecular and Cellular Insights Illuminate Disease Mechanisms
Recent studies reveal novel molecular pathways impacting multiple diseases. EZH2 enzyme modulation affects T cell activation in liver cancer through the MIF-CD74 axis, impacting tumor immunity. A...
Innovations in Imaging and Genomic Technologies Enhance Disease Diagnosis
Technological advancements are improving the detection and characterization of complex diseases. Dovetail Genomics introduced LinkPrep™, combining DNA sequence with 3D genome architecture analysis...
FDA Approvals and Policy Updates Shape Biopharma Landscape
Key regulatory developments include FDA approval of a new generic medical abortion pill (mifepristone) and the addition of Jazz Pharmaceuticals and Roche’s lung cancer therapy combination some...
Herbal and Natural Compounds Show Promise in Disease Management
Research deepens understanding of traditional medicinal compounds in modern therapy. Atractylodes lancea demonstrates potential to improve cardio-renal function in metabolic syndrome models....
Jazz and Roche Win FDA Nod for Lung Cancer First-Line Maintenance
Jazz Pharmaceuticals and Roche secured FDA approval for a new combination therapy in extensive-stage small-cell lung cancer. The approval covers Zepzelca (lurbinectedin) combined with Tecentriq...